Matches in Wikidata for { <http://www.wikidata.org/entity/Q65390529> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q65390529 description "clinical trial" @default.
- Q65390529 description "ensayu clínicu" @default.
- Q65390529 description "klinisch onderzoek" @default.
- Q65390529 description "клінічне випробування" @default.
- Q65390529 name "Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above" @default.
- Q65390529 name "Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above" @default.
- Q65390529 type Item @default.
- Q65390529 label "Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above" @default.
- Q65390529 label "Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above" @default.
- Q65390529 prefLabel "Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above" @default.
- Q65390529 prefLabel "Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above" @default.
- Q65390529 P1132 Q65390529-8CEA13DC-2F89-4DEC-A7E4-266757C0262D @default.
- Q65390529 P1476 Q65390529-9C747280-4F3A-418D-ADF5-D0B69ED80A2F @default.
- Q65390529 P17 Q65390529-09542A30-EC3D-4D8C-ADAF-074942602499 @default.
- Q65390529 P17 Q65390529-123EA618-A60C-44C2-B530-5DED70260A4E @default.
- Q65390529 P17 Q65390529-325180C4-4231-4AFA-8100-3BD5060F551C @default.
- Q65390529 P17 Q65390529-533273D4-B470-47AE-96DC-528DCB0085FA @default.
- Q65390529 P17 Q65390529-DEB7AF9B-7B36-4FAB-B009-00482E11E628 @default.
- Q65390529 P17 Q65390529-E90EEBFC-53A3-49B2-BDAF-8C03A3ACE585 @default.
- Q65390529 P2899 Q65390529-4966A7E3-56F5-402B-BDCC-710A92229B6B @default.
- Q65390529 P3098 Q65390529-322152D0-CC97-4CE3-AD6C-3DBC4CA259AD @default.
- Q65390529 P31 Q65390529-587FDD61-CDC5-488F-8781-F8D24CD86F48 @default.
- Q65390529 P580 Q65390529-0764FE29-B1E8-474F-BBEF-EEA92EB90A83 @default.
- Q65390529 P582 Q65390529-0003C5B0-E58C-4224-AD66-340CC616E889 @default.
- Q65390529 P6099 Q65390529-BD24E822-568E-42E3-80FE-C7E0104884A9 @default.
- Q65390529 P6153 Q65390529-3D9DE500-8801-446A-B734-3E7947F44738 @default.
- Q65390529 P8363 Q65390529-F56BEFE3-E7A7-47F5-B4F6-1BA3F89323C3 @default.
- Q65390529 P859 Q65390529-38FAF7A2-A6F7-4C9A-A8ED-D1C577DA14F2 @default.
- Q65390529 P1132 "+5075" @default.
- Q65390529 P1476 "A Phase III, Observer-blind, Randomised Study to Evaluate the Safety and Immunogenicity of One and Two Administrations of Pandemic Monovalent (H5N1) Influenza Vaccine (Adjuvanted Split Virus Formulation) in Adults Aged 18 Years and Older" @default.
- Q65390529 P17 Q142 @default.
- Q65390529 P17 Q183 @default.
- Q65390529 P17 Q191 @default.
- Q65390529 P17 Q29 @default.
- Q65390529 P17 Q34 @default.
- Q65390529 P17 Q55 @default.
- Q65390529 P2899 "+18" @default.
- Q65390529 P3098 "NCT00319098" @default.
- Q65390529 P31 Q30612 @default.
- Q65390529 P580 "2006-05-01T00:00:00Z" @default.
- Q65390529 P582 "2007-01-01T00:00:00Z" @default.
- Q65390529 P6099 Q42824827 @default.
- Q65390529 P6153 Q212322 @default.
- Q65390529 P8363 Q78089383 @default.
- Q65390529 P859 Q212322 @default.